Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis
Sonja Ständer(Klinik für Schlafmedizin), Tamas Almadi, Matthias Augustin(Universität Hamburg), Norbert Sepp, Johannes Wohlrab, Andrew Pink, Michael Sticherling(Universitätsklinikum Erlangen), Timo Buhl(Universitätsmedizin Göttingen), Christophe Piketty(Galderma (Switzerland)), Andrei I. Metelitsa(University of Calgary), Gil Yosipovitch(University of Miami), Alexander Zink(Technical University of Munich), Sascha Gerdes(Christian-Albrechts-Universität zu Kiel), Neil J. Korman(University Hospitals of Cleveland), Petra Staubach(Johannes Gutenberg University Mainz), Franziska Ruëff(LMU Klinikum), Zarif K. Jabbar‐Lopez(Galderma (Switzerland)), Amir S. Yazdi(Universitätsklinikum Aachen), Maria Concetta Fargnoli(University of L'Aquila), Athanasios Tsianakas(Zentralklinik Bad Berka), Adam Reich(Rzeszów University of Technology), Laura Maintz, Franz J. Legat(Medical University of Graz), Bernhard Homey(Düsseldorf University Hospital), Martin Metz(Humboldt-Universität zu Berlin), Dagmar Simon(University of Bern), Shawn G. Kwatra(University of Maryland, Baltimore), Lyn Guenther(Western University), Andreas Wollenberg(University Hospital Augsburg), Matthias Goebeler(University of Würzburg), Elke Weißhaar(Heidelberg University), Gregor Holzer, Giuseppe Micali(University of Catania), Howard Sofen(VA Sepulveda Ambulatory Care Center), C. Paul(Université Fédérale de Toulouse Midi-Pyrénées), Nikolaos Patsinakidis(University of Münster), Diamant Thaçi(University of Lübeck), Simon Fage(Aarhus University Hospital), Kirsten Walker(Queen's University), Kristian Reich(Dermatologikum Hamburg), Maurizio Podda(Goethe University Frankfurt), Kemeny Lajos, Luigi Naldi(Centro Studi GISED), Hema Sundaram(University of Manchester), Xiaoxiao Chen(Chinese Academy of Sciences), Lone Skov(University of Copenhagen)
Cited by 57
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k